Estefi Alvarez, Phd Email and Phone Number
Estefi Alvarez, Phd work email
- Valid
- Valid
Estefi Alvarez, Phd personal email
- Valid
Estefi is a patient-centered business strategist and advisor with a tenure of leadership translating long term strategy to execution, enabling healthcare transformation in the medical devices, healthtech and life sciences industry. Estefi brings value-added impact to patients, providers and healthcare system, while driving revenue and profit-critical decision making for investment, portfolio pipeline building, M&A and licensing/distribution deals delivering +$100M since 2019. Estefi is a proactive leader that seeks out and establishes long lasting relationships with decision makers within industry, providers, policy makers. Estefi assists global companies to unlock, implement and execute actionable growth strategies for value creation and to fast track innovation and commercialization to bring patient centric technologies to market, expand patient access, improve clinical outcomes and reduce cost to the healthcare system. Estefi has experience across a broad range of diagnostic and treatment applications including products and services in: in vitro & POC diagnostics, diagnostic imaging, minimally invasive image guided treatment & monitoring devices, biologics, robotics, digital health, AI/ML analytics, orthopedics, women’s health, dialysis, urology, drug delivery, wound care, nuclear medicine. ✦ Estefi is a big-picture thinker with an ability to balance strategic thinking and tactical execution, leveraging her hands-on clinical, commercial and market access foundations, solid academic background, and regulatory savviness. She is a recognized high performing motivational leader with superb interpersonal and stakeholder management skills and proven cross-functional project leadership. She has a unique blend of technical and clinical knowledge that has enabled her to led cross-functional teams (R&D, Marketing, Regulatory, BD) to successfully translate unmet needs into solutions and bringing them through commercialization. She is an innovator at heart, awarded two patents & several applications. ✦ Estefi applies her industry know how to her management consulting leadership delivering actionable commercial and operational strategies that inform decision making and create value. ✦ She also active in the investment community as a SomosVC Fellow, EIR at Yales Ventures advising startup companies, and she is a co-chair of Programming at MedtchWomen and LGBTQ+ organizations.
Cepheid
View- Website:
- cepheid.com
- Employees:
- 4760
-
Director Product Innovation ManagementCepheidSan Francisco, Ca, Us
-
Entrepreneur In ResidenceYale VenturesNew York, Ny, Us -
Manager, Healthcare And Life SciencesSimon-Kucher Jun 2024 - PresentBonn, De -
Vc FellowSomosvc Apr 2024 - Present -
Entrepreneur In ResidenceYale Ventures Sep 2023 - PresentNew Haven, Ct, UsYale Ventures Entrepreneurs-in-Residence (EIRs) have deep operational experience and have gone through the process of turning new technologies to new businesses. Serve as an early “sounding board” for Yale innovators contemplating a new startup. In a logical, stepwise fashion, EIRs help frame both the risks and the benefits of starting a new company, asking relevant questions about everything from the science, to the business, to the market and helping faculty chart a successful path forward and explore additional fundraising opportunities. Directly contribute to PIs and Yale Ventures' team by bringing in hands-on expertise developing, launching and commercializing medtech & digital health platforms, as well as established network within industry and the investment community. -
PrincipalAlira Health Apr 2023 - Jul 2023Framingham, Massachusetts, UsAs a Principal, Estefi successfully sourced, closed and executed a wide range of engagements with global companies (startups to strategically) delivering actionable recommendations and value by leading a variety of engagements e.g., go to market strategy, commercial due diligence, market landscape, opportunity assessment, market access strategy, commercial strategy & pricing. -
Associate Director Global Market AccessAlira Health Mar 2022 - Apr 2023Framingham, Massachusetts, Us
-
Senior Consultant - Global Market Access, MedtechAlira Health Dec 2020 - Mar 2022Framingham, Massachusetts, UsAs a seasoned strategic leader, drives client engagement for global Medtech and Pharma clients providing project leadership, domain and industry experience, and develops new business to support the growth and industry leadership of Alira's Global Market Access Practice (GMA). GMA is a multidisciplinary, global team focused on helping clients navigate the rapidly changing payer environment, and recommending actionable strategies to address complex evidence requirements and breakdown payer barriers to achieve optimal price and access. Areas of expertise include: healthcare economic and outcomes research (HEOR), value based pricing, reimbursement, market access strategies, value proposition development, value messaging, payer landscape & positioning, clinical strategy, regulatory strategy, KOL engagement and board development, licensing and potential partnership/strategics recommendations, commercial due diligence.Hands-on knowledge of global healthcare systems, regulations and reimbursement processes for devices and pharmaceuticals (USA, Europe) to inform and de-risk clients’ organic and inorganic strategies and deliver a roadmap for short and long term actionable recommendations and evidence generation milestones. Collaborates with internal and external stakeholders in order to plan, validate and execute value demonstration studies and data collection projects to generate required clinical and economic evidence that would drive adoption and meet payers’ expectations for reimbursement.Validates and refines product and service value propositions by leveraging insights uncovered through primary (Qualitative and Quantitative), secondary research activities, market/competitive research. Develops product specific value evidence strategies and communications by identifying health and economic outcomes research (endpoints) needed to be met in order to fulfill payers’ expectations and enable providers’ and patients’ adoption.
-
Senior Scientist, Innovation, Business Development, Surgical DivisionHologic, Inc. 2016 - 2020Marlborough, Ma, UsFor $3 billion, publicly traded women’s health medical devices company, played key role in multi-disciplinary science team translating clinical and global market insights into actionable corporate/business development and pipeline decisions.Led company’s entry, from concept to product development, into the adjacent market via an acquisition. Innovated in minimally invasive, image-guided bladder and uterine pathology solutions including prototype development. Completed due diligence and provided actionable recommendations that led to one direct distribution and three product development licensing deals. Advanced projects for two commercial tissue removal solutions, fibroids, biopsies, endometrial ablation, and both core and adjacent-space products in pelvic, uterine and urology sectors. As a key player in corporate decision-making, integrated business strategy, technical, clinical, regulatory, competitive market/revenue potential, and risk mitigation issues. Weighed organic versus external development options. Partnered with academic and clinical partners. Spearheaded and executed pre-clinical animal models, supported clinical trial executions and strategies for FDA pre-market approval submissions.Won recognition for corporate leadership potential as one of fewer than 1% of Hologic staff – most at vice president level – selected for prestigious leadership development program conducted by outside management consulting firm. -
Advanced Technology Scientist Ii, Business Development, Breast Health DivisionHologic, Inc. 2013 - 2016Marlborough, Ma, UsAs the only member of a 20-scientist multidisciplinary team focused on interventional breast health technologies, laid the foundation for the company’s profitable development of a full continuum of breast care solutions (diagnostic, treatment, surgical, post-operative), encompassing internal product development, company acquisitions and licensing deals.Drove research and business due diligence leading directly to later $125 and $80 million acquisitions of breast surgery marker (Focal Therapeutics) and digital specimen radiology (Faxitron Bioptics) companies. Identified, led due diligence and partnered on clinical trial for image-based biopsy implant technology from Germany’s Somatex, leading to development/distribution deal and commercial launch generating $5 million in annual revenue.Benchmarked Hologic’s portfolio against competitors’ to win corporate leadership support for targeted technology solutions for biopsies, implants, biomarker cancer diagnosis & monitoring and MRI-based platform in urology market. Presented pre-clinical model to FDA for Brevara automated X-ray guided breast biopsy system leading to 510(k) approval; and provided expert Brevera and Sertera (ultrasound-guided biopsy) launch/commercialization support.
-
Post-Doctoral Fellow, Bioengineering DepartmentClemson University 2012 - 2013Clemson, Sc, UsAt state-of-the-art Biomedical Innovation Campus, led Institutional Review Board (IRB)-sanctioned post-market surveillance program for total joint replacements. Built partnerships with two biotech companies on joint replacement projects. -
Graduate Research/Teaching AssistantClemson University 2008 - 2012Clemson, Sc, UsLed team that developed/validated predictive test model to assess damage/failure of joint replacement components, improving industry and FDA guidelines. Also led DJO Surgical company-sponsored testing/report on knee replacement product that won FDA 510(k) approval. Built alliances with orthopedic surgeons and four hospital systems for academic research/clinical partnerships and new statewide Implant Retrieval System, as well as with Hospital of Special Surgery (NY) and UC Berkeley.
-
Research And Development EngineerBoston Scientific 2006 - 2007Marlborough, Ma, UsFor $9 billion, publicly traded manufacturer of devices for interventional medical specialties, led failure investigation and recommended design changes for new Endovations disposable endoscope product.
Estefi Alvarez, Phd Skills
Estefi Alvarez, Phd Education Details
-
Clemson UniversityBioengineering -
Alfred UniversityMaterials Science And Engineering
-
Smith CollegeMechanical (Minor In Economics)
Frequently Asked Questions about Estefi Alvarez, Phd
What company does Estefi Alvarez, Phd work for?
Estefi Alvarez, Phd works for Cepheid
What is Estefi Alvarez, Phd's role at the current company?
Estefi Alvarez, Phd's current role is Director Product Innovation Management.
What is Estefi Alvarez, Phd's email address?
Estefi Alvarez, Phd's email address is es****@****ail.com
What schools did Estefi Alvarez, Phd attend?
Estefi Alvarez, Phd attended Clemson University, Alfred University, Smith College.
What skills is Estefi Alvarez, Phd known for?
Estefi Alvarez, Phd has skills like Medical Devices, Biomaterials, Biotechnology, Business Development, Product Innovation, Business Strategy, Portfolio Management, Concept Development, Due Diligence, Strategy, Product Development, Research And Development.
Who are Estefi Alvarez, Phd's colleagues?
Estefi Alvarez, Phd's colleagues are Satya Ashok Kumar, Steven Lieu, Alayah Nylah, Cristiane Lauton, D M, Kenneth Forsthoff, Loshnee Vandayar.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial